April 2009 Briefing - RheumatologyLast Updated: May 01, 2009.
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for April 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
New Web-based Information Source to Support UK Clinicians
THURSDAY, April 30 (HealthDay News) -- The United Kingdom's National Institute for Health and Clinical Excellence (NICE) has announced the launch of NHS Evidence, a Web-based evidence resource for clinicians, public health professionals of the National Health Service, and others involved in making patient care decisions. The announcement came in the April 30 issue of The Lancet.
NEJM Commends New Conflict of Interest Proposal
THURSDAY, April 30 (HealthDay News) -- A new proposal to control conflict of interest is notable for its breadth and variety of recommended solutions, according to a Perspective article published online April 29 in the New England Journal of Medicine.
FDA Requires OTC Pain Relievers to Display Warnings
WEDNESDAY, April 29 (HealthDay News) -- Popular over-the-counter (OTC) pain relievers and fever medications containing acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) will be required to display prominent warnings about the risks of liver damage and internal bleeding, under a new rule announced April 28 by the U.S. Food and Drug Administration (FDA).
Naltrexone Linked to Improved Fibromyalgia Symptoms
WEDNESDAY, April 29 (HealthDay News) -- Low-dose naltrexone (LDN) may be useful in treating fibromyalgia, according to research published online April 22 in Pain Medicine.
Pharmacist Involvement May Decrease Medication Errors
TUESDAY, April 28 (HealthDay News) -- Adding a pharmacist to health care teams may significantly decrease patients' risk of adverse drug events and medication errors, according to a report published in the April 27 issue of the Archives of Internal Medicine. A second study indicates that an interdisciplinary medication reconciliation intervention can also reduce unintentional medication discrepancies with potential for harm.
Steep Copayments Increase Risk of Non-Adherence
TUESDAY, April 28 (HealthDay News) -- In patients who are newly diagnosed with a chronic disease, higher out-of-pocket costs for medications are associated with an increased likelihood of non-treatment, according to a study published in the April 27 issue of the Archives of Internal Medicine.
Shoe Insoles Don't Appear to Prevent Back Pain
THURSDAY, April 23 (HealthDay News) -- Shoe insoles do not appear to be effective for preventing back pain, and limited evidence neither supports nor discourages their use for treating low back pain, according to research published April 20 in Spine.
Having Health Insurance May Not Improve Mortality Risk
THURSDAY, April 23 (HealthDay News) -- People without health insurance have about the same mortality rate as people with health insurance, according to an observational study published online April 21 in Health Services Research.
Oral Bisphosphonates Link to Esophageal Cancer Analyzed
WEDNESDAY, April 22 (HealthDay News) -- Oral bisphosphonate does not appear to increase risk for esophageal cancer, according to analyses of Danish and U.S. data reported by separate researchers in the April 23 issue of the New England Journal of Medicine.
Stretches Without Health Insurance More Common
WEDNESDAY, April 22 (HealthDay News) -- Periods of uninsurance have become more common in recent decades, particularly among those with less education, according to research published in the April 23 issue of the New England Journal of Medicine.
Continuity of Care Declining for Medicare Beneficiaries
TUESDAY, April 21 (HealthDay News) -- Medicare beneficiaries in the hospital in 2006 were much less likely to be seen there by a familiar physician than those in the hospital a decade earlier, according to a study reported in the April 22/29 issue of the Journal of the American Medical Association.
Spine Patients Choose Surgery to Improve Functioning
FRIDAY, April 17 (HealthDay News) -- Improving daily functioning, such as walking, rather than relieving pain is the primary reason that people with back deformities choose risky surgery over nonoperative therapies, according to a report in the April 15 issue of Spine.
Disturbed Sleep Common in Patients With Psoriasis
FRIDAY, April 17 (HealthDay News) -- In patients with psoriasis, psoriatic arthritis and several other factors are predictors of sleep interference, according to a study published in the April issue of the Journal of the American Academy of Dermatology.
Gastrointestinal Symptoms Common in Fibromyalgia
THURSDAY, April 16 (HealthDay News) -- A large majority of individuals with fibromyalgia also had functional gastrointestinal disorders (FGID), which may be related to psychological distress, according to research published in the April issue of Clinical Gastroenterology and Hepatology.
Clinicians Often Unaware of Alternative Medicine Trials
TUESDAY, April 14 (HealthDay News) -- Among practicing clinicians, awareness of complementary and alternative medicine (CAM) randomized controlled trials and confidence in ability to interpret the results is generally low, according to study findings published in the April 13 issue of the Archives of Internal Medicine.
Review Looks at Injuries in Spinal Disorders
MONDAY, April 13 (HealthDay News) -- A review of outcomes following spinal injuries in individuals with ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis (DISH) suggests appropriate management strategies in these cases, according to research published in the April issue of the Journal of Spinal Disorders & Techniques.
Financial Rewards for Healthy Behavior Can Be Effective
FRIDAY, April 10 (HealthDay News) -- Although paying people to engage in healthy behaviors or successfully tackle unhealthy ones can be effective, it may carry unintended consequences, according to an editorial published online April 9 in BMJ.
Blacks, Whites Differ in Arthritis Treatment Concerns
FRIDAY, April 10 (HealthDay News) -- Blacks and whites with rheumatoid arthritis attach greater importance to differing factors related to treatment, according to research published in the April 15 issue of Arthritis Care & Research.
Golimumab Linked to Psoriatic Arthritis Improvements
FRIDAY, April 10 (HealthDay News) -- Golimumab, a human monoclonal antibody against tumor necrosis factor alpha (TNFα), showed benefits in adults with psoriatic arthritis, according to research published in the April issue of Arthritis & Rheumatism.
No Role of Antibody in Arthritis Heritability
THURSDAY, April 9 (HealthDay News) -- The presence of anti-citrullinated protein antibodies (ACPA) in patients with rheumatoid arthritis, which are highly predictive of the disease course, does not have a role in the heritability of the disease, according to research published in the April issue of Arthritis & Rheumatism.
Oral Contraceptive Use May Increase Risk of Lupus
WEDNESDAY, April 8 (HealthDay News) -- Using combined oral contraceptives increases the risk of systemic lupus erythematosus, particularly when starting to use the drug, according to research published in the April 15 issue of Arthritis Care & Research.
Electronic Prescribing Online-Learning Tools Launched
THURSDAY, April 2 (HealthDay News) -- U.S. physicians will be able to better evaluate electronic prescribing systems thanks to a new online learning center on ePrescribing launched April 1 by the American Medical Association.
Changes Needed in New-Drug Evaluation Process
WEDNESDAY, April 1 (HealthDay News) -- The evaluation process for new drugs is overdue for an overhaul, which could provide benefits for the public and the pharmaceutical industry, according to a point-counterpoint commentary published online March 31 in BMJ.
New Health Program Leads to Questions in the UK
WEDNESDAY, April 1 (HealthDay News) -- A new British program to improve patient choices and competition in the health care marketplace may lead to excess capacity in some areas and instability in others, according to a commentary published online March 31 in BMJ.